Akari Therapeutics (AKTX) Cash & Equivalents (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.80% |
| Dec 31, 2025 | 3,100.53% |
| Sep 30, 2025 | -94.00% |
| Jun 30, 2025 | 5.00% |
| Mar 31, 2025 | -0.65% |
| Dec 31, 2024 | 15.72% |
| Sep 30, 2024 | -46.23% |
| Jun 30, 2024 | 218.85% |
| Mar 31, 2024 | -65.93% |
| Jun 30, 2022 | -51.26% |
| Mar 31, 2022 | 179,345.25% |
| Dec 31, 2021 | -99.93% |
| Sep 30, 2021 | -4.73% |
| Jun 30, 2021 | 110.78% |
| Mar 31, 2021 | -99.88% |
| Dec 31, 2020 | 46,304.40% |
| Sep 30, 2020 | -3.36% |
| Jun 30, 2020 | 62.95% |
| Mar 31, 2020 | 36.85% |
| Dec 31, 2019 | -4.22% |
| Sep 30, 2019 | 118.07% |
| Jun 30, 2019 | -54.14% |
| Mar 31, 2019 | 0.91% |
| Dec 31, 2018 | -41.29% |
| Sep 30, 2018 | -33.16% |
| Jun 30, 2018 | -36.63% |
| Mar 31, 2018 | -15.39% |
| Dec 31, 2017 | 34.01% |
| Sep 30, 2017 | -38.49% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -0.05% |
| Dec 31, 2016 | -50.50% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 12.19% |
| Mar 31, 2016 | -10.87% |
| Dec 31, 2015 | 1,971.24% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 150.44% |
| Mar 31, 2015 | -60.07% |
| Dec 31, 2014 | 6,224.30% |
| Sep 30, 2014 | -99.54% |
| Jun 30, 2014 | -17.86% |
| Mar 31, 2014 | 2,397.59% |